Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas.

Leukemia & lymphoma - 1 Mar 1998

Navaratnam S, Williams G J, Rubinger M, Pettigrew N M, Mowat M R, Begleiter A, Johnston J B

Abstract excerpt

Approximately 50% of patients with aggressive non-Hodgkin's lymphomas (NHL) achieve a complete remission (CR) and cure with combination chemotherapy. The International Index is a useful clinical measure that predicts the patients' tolerance of therapy and likelihood of achieving CR, but it is not a direct measure of chemosensitivity. In this study we have investigated the predictive value of the tumor suppressor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Doxorubicin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Lymphoma, Non-Hodgkin

Share to Mutation

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 9638983
DOI: 10.3109/10428199809058389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas.PMID 9638983Read ↗

Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.Semantic proximity Read ↗

Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma.Semantic proximity Read ↗

The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma.Semantic proximity Read ↗

Expressions of p53 and PCNA do not correlate with the international index or early response to chemotherapy in non-Hodgkin's lymphoma.Semantic proximity Read ↗

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.Semantic proximity Read ↗

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.Semantic proximity Read ↗

The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status.Semantic proximity Read ↗

Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma.Semantic proximity Read ↗

Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.Semantic proximity Read ↗

Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.Semantic proximity Read ↗

Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas.Semantic proximity Read ↗

p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.